Latest Healthcare Research Reports

Tag: genome editing market segment

  • Genome Editing/Genome Engineering Market Expected To Reach $24.52 Billion By 2030 As Growth Accelerates At 19.2% CAGR

    Genome Editing/Genome Engineering Market Expected To Reach $24.52 Billion By 2030 As Growth Accelerates At 19.2% CAGR

    Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

    Genome Editing/Genome Engineering Market Growth Potential: How Will Market Size Change Through 2030?

    The sector dedicated to genome editing and engineering has experienced significant expansion lately, with projections indicating a rise from $10.17 billion in 2025 to $12.15 billion in 2026, reflecting a compound annual growth rate of 19.5%. Factors fueling this past growth include the advent of genome editing methodologies, initial research applications, the proliferation of molecular biology instrumentation, increased investment in academic research, and a heightened need for disease modeling.

    The field of genome editing, also referred to as genome engineering, is projected to experience substantial expansion in the upcoming years, reaching an estimated market value of $24.53 billion by 2030. This impressive growth trajectory is underpinned by a compound annual growth rate (CAGR) of 19.2%, fueled by several key drivers. These include the progression of gene editing therapies into clinical applications, the broadening scope of agricultural genomics, advancements leading to more precise editing capabilities, the establishment of ethical guidelines, and the increasing commercial availability of genome editing services. Furthermore, several significant trends are anticipated to shape this market during the forecast period, such as a greater reliance on CRISPR-based editing technologies, the expanding application of genome editing within disease research, a rise in the utilization of cell line engineering for various purposes, a growing need for highly accurate gene modification techniques, and increased investment in academic and governmental research initiatives.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=8010&type=smp

    Genome Editing/Genome Engineering Market Growth Drivers: What Factors Are Accelerating Expansion?

    The expansion of the genome editing and genome engineering sector is anticipated to be propelled by a rise in scientific investigations. These investigations encompass structured endeavors undertaken by individuals, groups, or organizations aimed at acquiring, examining, interpreting, and producing novel understanding within a specific domain. Genome editing and engineering technologies are now central to the burgeoning volume of research, reshaping how scientific inquiry is conducted. Such advanced methodologies enable scientists to precisely alter and understand the complex genetic makeup of living things, providing exceptional accuracy and adaptability. For example, the National Institute of Neurological Disorders and Stroke, a US government research body, announced in July 2023 that the NIH was allocating over $140 million to expedite the translation of genome editing techniques from laboratory settings to clinical applications. Consequently, an escalation in research initiatives serves as a primary impetus for the growth of the genome editing and genome engineering market.

    Genome Editing/Genome Engineering Market Segment Breakdown: Which Categories Generate The Most Revenue?

    The genome editing/genome engineering market covered in this report is segmented –

    1) By Product And Service: Reagents And Consumables, Software And Systems, Services

    2) By Technology: CRISPR, TALEN, ZFN, Antisense, Other Technologies

    3) By Application: Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery And Development, Other Applications

    4) By End User: Biotechnology Companies, Pharmaceutical Companies, Academic And Government Research Institutes

    Subsegments:

    1) By Reagents And Consumables: CRISPR Or Cas9 Kits, TALENs Kits, Zinc Finger Nucleases (ZFNs), Donor DNA Templates, Nucleotide Reagents

    2) By Software And Systems: Genome Editing Design Software, Analysis And Visualization Tools, Workflow Management Systems

    3) By Services: Gene Synthesis And Cloning Services, Custom Genome Editing Services, Consulting Services For Genome Editing Projects

    Genome Editing/Genome Engineering Market Trends: What Is Shaping Future Industry Growth?

    In the competitive landscape of genome editing and genome engineering, prominent entities frequently engage in alliances to enhance their market standing. Such strategic business partnerships signify formal cooperative arrangements among multiple commercial organizations, typically formalized through contractual agreements. An illustrative example occurred in April 2024 when Regeneron Pharmaceuticals, an American biopharmaceutical firm dedicated to pioneering treatments for immunological disorders, cancers, and genetic conditions, joined forces with Mammoth Biosciences, a US biotechnology enterprise co-founded by Jennifer Doudna and renowned for its specialization in CRISPR gene editing. Through this collaboration, Regeneron intends to harness Mammoth’s exceptionally compact CRISPR technologies alongside Regeneron’s established delivery systems to expedite the creation of in vivo gene editing interventions targeting tissues outside the liver, consequently broadening Regeneron’s scope of therapeutic offerings and technological capabilities. Mammoth Biosciences, a company headquartered in the United States, furnishes CRISPR-driven genome editing solutions, encompassing its proprietary compact Cas enzymes, for both therapeutic and diagnostic purposes.

    Genome Editing/Genome Engineering Market Key Players And Strategic Industry Positioning

    Major companies operating in the genome editing/genome engineering market are Thermo Fisher Scientific Inc., Merck Group, Genscript Biotech Corp, Sangamo Therapeutics Inc., Lonza Group AG, Editas Medicine Inc., CRISPR Therapeutics AG, Agilent Technologies Inc., Intellia Therapeutics, bluebird bio Inc., Transposagen Biopharmaceuticals Inc., Tecan Trading AG, Precision BioSciences, PerkinElmer Inc., Cellectis S.A, Applied StemCell Inc., Bio-Rad Laboratories Inc., Bio-Techne, Creative Biogene, Cyagen Biosciences, Dharmacon Inc., Eurofins Genomics LLC, Evotec SE, GeneCopoeia Inc., Genewiz, Horizon Discovery Group PLC, Inscripta Inc., Integrated DNA Technologies Inc., MaxCyte Inc., New England Biolabs, Novartis International AG.

    Access The Complete Genome Editing/Genome Engineering Market Report:

    https://www.thebusinessresearchcompany.com/report/genome-editing-or-genome-engineering-global-market-report

    Genome Editing/Genome Engineering Market Regional Analysis: Which Region Leads By Revenue?

    North Americawas the largest region in the gene editing/genome engineering market in 2025. Asia-Pacificis expected to be the fastest-growing region in the genome editing/genome engineering market report during the forecast period. The regions covered in the genome editing/genome engineering market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Genome Editing/Genome Engineering Market Expected To Reach $24.52 Billion By 2030 As Growth Accelerates At 19.2% CAGR

    Genome Editing/Genome Engineering Market Expected To Reach $24.52 Billion By 2030 As Growth Accelerates At 19.2% CAGR

    Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

    Genome Editing/Genome Engineering Market Growth Potential: How Will Market Size Change Through 2030?

    The sector dedicated to genome editing and engineering has experienced significant expansion lately, with projections indicating a rise from $10.17 billion in 2025 to $12.15 billion in 2026, reflecting a compound annual growth rate of 19.5%. Factors fueling this past growth include the advent of genome editing methodologies, initial research applications, the proliferation of molecular biology instrumentation, increased investment in academic research, and a heightened need for disease modeling.

    The field of genome editing, also referred to as genome engineering, is projected to experience substantial expansion in the upcoming years, reaching an estimated market value of $24.53 billion by 2030. This impressive growth trajectory is underpinned by a compound annual growth rate (CAGR) of 19.2%, fueled by several key drivers. These include the progression of gene editing therapies into clinical applications, the broadening scope of agricultural genomics, advancements leading to more precise editing capabilities, the establishment of ethical guidelines, and the increasing commercial availability of genome editing services. Furthermore, several significant trends are anticipated to shape this market during the forecast period, such as a greater reliance on CRISPR-based editing technologies, the expanding application of genome editing within disease research, a rise in the utilization of cell line engineering for various purposes, a growing need for highly accurate gene modification techniques, and increased investment in academic and governmental research initiatives.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=8010&type=smp

    Genome Editing/Genome Engineering Market Growth Drivers: What Factors Are Accelerating Expansion?

    The expansion of the genome editing and genome engineering sector is anticipated to be propelled by a rise in scientific investigations. These investigations encompass structured endeavors undertaken by individuals, groups, or organizations aimed at acquiring, examining, interpreting, and producing novel understanding within a specific domain. Genome editing and engineering technologies are now central to the burgeoning volume of research, reshaping how scientific inquiry is conducted. Such advanced methodologies enable scientists to precisely alter and understand the complex genetic makeup of living things, providing exceptional accuracy and adaptability. For example, the National Institute of Neurological Disorders and Stroke, a US government research body, announced in July 2023 that the NIH was allocating over $140 million to expedite the translation of genome editing techniques from laboratory settings to clinical applications. Consequently, an escalation in research initiatives serves as a primary impetus for the growth of the genome editing and genome engineering market.

    Genome Editing/Genome Engineering Market Segment Breakdown: Which Categories Generate The Most Revenue?

    The genome editing/genome engineering market covered in this report is segmented –

    1) By Product And Service: Reagents And Consumables, Software And Systems, Services

    2) By Technology: CRISPR, TALEN, ZFN, Antisense, Other Technologies

    3) By Application: Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery And Development, Other Applications

    4) By End User: Biotechnology Companies, Pharmaceutical Companies, Academic And Government Research Institutes

    Subsegments:

    1) By Reagents And Consumables: CRISPR Or Cas9 Kits, TALENs Kits, Zinc Finger Nucleases (ZFNs), Donor DNA Templates, Nucleotide Reagents

    2) By Software And Systems: Genome Editing Design Software, Analysis And Visualization Tools, Workflow Management Systems

    3) By Services: Gene Synthesis And Cloning Services, Custom Genome Editing Services, Consulting Services For Genome Editing Projects

    Genome Editing/Genome Engineering Market Trends: What Is Shaping Future Industry Growth?

    In the competitive landscape of genome editing and genome engineering, prominent entities frequently engage in alliances to enhance their market standing. Such strategic business partnerships signify formal cooperative arrangements among multiple commercial organizations, typically formalized through contractual agreements. An illustrative example occurred in April 2024 when Regeneron Pharmaceuticals, an American biopharmaceutical firm dedicated to pioneering treatments for immunological disorders, cancers, and genetic conditions, joined forces with Mammoth Biosciences, a US biotechnology enterprise co-founded by Jennifer Doudna and renowned for its specialization in CRISPR gene editing. Through this collaboration, Regeneron intends to harness Mammoth’s exceptionally compact CRISPR technologies alongside Regeneron’s established delivery systems to expedite the creation of in vivo gene editing interventions targeting tissues outside the liver, consequently broadening Regeneron’s scope of therapeutic offerings and technological capabilities. Mammoth Biosciences, a company headquartered in the United States, furnishes CRISPR-driven genome editing solutions, encompassing its proprietary compact Cas enzymes, for both therapeutic and diagnostic purposes.

    Genome Editing/Genome Engineering Market Key Players And Strategic Industry Positioning

    Major companies operating in the genome editing/genome engineering market are Thermo Fisher Scientific Inc., Merck Group, Genscript Biotech Corp, Sangamo Therapeutics Inc., Lonza Group AG, Editas Medicine Inc., CRISPR Therapeutics AG, Agilent Technologies Inc., Intellia Therapeutics, bluebird bio Inc., Transposagen Biopharmaceuticals Inc., Tecan Trading AG, Precision BioSciences, PerkinElmer Inc., Cellectis S.A, Applied StemCell Inc., Bio-Rad Laboratories Inc., Bio-Techne, Creative Biogene, Cyagen Biosciences, Dharmacon Inc., Eurofins Genomics LLC, Evotec SE, GeneCopoeia Inc., Genewiz, Horizon Discovery Group PLC, Inscripta Inc., Integrated DNA Technologies Inc., MaxCyte Inc., New England Biolabs, Novartis International AG.

    Access The Complete Genome Editing/Genome Engineering Market Report:

    https://www.thebusinessresearchcompany.com/report/genome-editing-or-genome-engineering-global-market-report

    Genome Editing/Genome Engineering Market Regional Analysis: Which Region Leads By Revenue?

    North Americawas the largest region in the gene editing/genome engineering market in 2025. Asia-Pacificis expected to be the fastest-growing region in the genome editing/genome engineering market report during the forecast period. The regions covered in the genome editing/genome engineering market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Genome Editing/Genome Engineering Market Expected To Reach $24.52 Billion By 2030 As Growth Accelerates At 19.2% CAGR

    Genome Editing/Genome Engineering Market Expected To Reach $24.52 Billion By 2030 As Growth Accelerates At 19.2% CAGR

    Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

    Genome Editing/Genome Engineering Market Growth Potential: How Will Market Size Change Through 2030?

    The sector dedicated to genome editing and engineering has experienced significant expansion lately, with projections indicating a rise from $10.17 billion in 2025 to $12.15 billion in 2026, reflecting a compound annual growth rate of 19.5%. Factors fueling this past growth include the advent of genome editing methodologies, initial research applications, the proliferation of molecular biology instrumentation, increased investment in academic research, and a heightened need for disease modeling.

    The field of genome editing, also referred to as genome engineering, is projected to experience substantial expansion in the upcoming years, reaching an estimated market value of $24.53 billion by 2030. This impressive growth trajectory is underpinned by a compound annual growth rate (CAGR) of 19.2%, fueled by several key drivers. These include the progression of gene editing therapies into clinical applications, the broadening scope of agricultural genomics, advancements leading to more precise editing capabilities, the establishment of ethical guidelines, and the increasing commercial availability of genome editing services. Furthermore, several significant trends are anticipated to shape this market during the forecast period, such as a greater reliance on CRISPR-based editing technologies, the expanding application of genome editing within disease research, a rise in the utilization of cell line engineering for various purposes, a growing need for highly accurate gene modification techniques, and increased investment in academic and governmental research initiatives.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=8010&type=smp

    Genome Editing/Genome Engineering Market Growth Drivers: What Factors Are Accelerating Expansion?

    The expansion of the genome editing and genome engineering sector is anticipated to be propelled by a rise in scientific investigations. These investigations encompass structured endeavors undertaken by individuals, groups, or organizations aimed at acquiring, examining, interpreting, and producing novel understanding within a specific domain. Genome editing and engineering technologies are now central to the burgeoning volume of research, reshaping how scientific inquiry is conducted. Such advanced methodologies enable scientists to precisely alter and understand the complex genetic makeup of living things, providing exceptional accuracy and adaptability. For example, the National Institute of Neurological Disorders and Stroke, a US government research body, announced in July 2023 that the NIH was allocating over $140 million to expedite the translation of genome editing techniques from laboratory settings to clinical applications. Consequently, an escalation in research initiatives serves as a primary impetus for the growth of the genome editing and genome engineering market.

    Genome Editing/Genome Engineering Market Segment Breakdown: Which Categories Generate The Most Revenue?

    The genome editing/genome engineering market covered in this report is segmented –

    1) By Product And Service: Reagents And Consumables, Software And Systems, Services

    2) By Technology: CRISPR, TALEN, ZFN, Antisense, Other Technologies

    3) By Application: Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery And Development, Other Applications

    4) By End User: Biotechnology Companies, Pharmaceutical Companies, Academic And Government Research Institutes

    Subsegments:

    1) By Reagents And Consumables: CRISPR Or Cas9 Kits, TALENs Kits, Zinc Finger Nucleases (ZFNs), Donor DNA Templates, Nucleotide Reagents

    2) By Software And Systems: Genome Editing Design Software, Analysis And Visualization Tools, Workflow Management Systems

    3) By Services: Gene Synthesis And Cloning Services, Custom Genome Editing Services, Consulting Services For Genome Editing Projects

    Genome Editing/Genome Engineering Market Trends: What Is Shaping Future Industry Growth?

    In the competitive landscape of genome editing and genome engineering, prominent entities frequently engage in alliances to enhance their market standing. Such strategic business partnerships signify formal cooperative arrangements among multiple commercial organizations, typically formalized through contractual agreements. An illustrative example occurred in April 2024 when Regeneron Pharmaceuticals, an American biopharmaceutical firm dedicated to pioneering treatments for immunological disorders, cancers, and genetic conditions, joined forces with Mammoth Biosciences, a US biotechnology enterprise co-founded by Jennifer Doudna and renowned for its specialization in CRISPR gene editing. Through this collaboration, Regeneron intends to harness Mammoth’s exceptionally compact CRISPR technologies alongside Regeneron’s established delivery systems to expedite the creation of in vivo gene editing interventions targeting tissues outside the liver, consequently broadening Regeneron’s scope of therapeutic offerings and technological capabilities. Mammoth Biosciences, a company headquartered in the United States, furnishes CRISPR-driven genome editing solutions, encompassing its proprietary compact Cas enzymes, for both therapeutic and diagnostic purposes.

    Genome Editing/Genome Engineering Market Key Players And Strategic Industry Positioning

    Major companies operating in the genome editing/genome engineering market are Thermo Fisher Scientific Inc., Merck Group, Genscript Biotech Corp, Sangamo Therapeutics Inc., Lonza Group AG, Editas Medicine Inc., CRISPR Therapeutics AG, Agilent Technologies Inc., Intellia Therapeutics, bluebird bio Inc., Transposagen Biopharmaceuticals Inc., Tecan Trading AG, Precision BioSciences, PerkinElmer Inc., Cellectis S.A, Applied StemCell Inc., Bio-Rad Laboratories Inc., Bio-Techne, Creative Biogene, Cyagen Biosciences, Dharmacon Inc., Eurofins Genomics LLC, Evotec SE, GeneCopoeia Inc., Genewiz, Horizon Discovery Group PLC, Inscripta Inc., Integrated DNA Technologies Inc., MaxCyte Inc., New England Biolabs, Novartis International AG.

    Access The Complete Genome Editing/Genome Engineering Market Report:

    https://www.thebusinessresearchcompany.com/report/genome-editing-or-genome-engineering-global-market-report

    Genome Editing/Genome Engineering Market Regional Analysis: Which Region Leads By Revenue?

    North Americawas the largest region in the gene editing/genome engineering market in 2025. Asia-Pacificis expected to be the fastest-growing region in the genome editing/genome engineering market report during the forecast period. The regions covered in the genome editing/genome engineering market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Genome Editing Market to Reach $24.52B by 2030

    Genome Editing Market to Reach $24.52B by 2030

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Expansion In Market Value Is Forecasted For The Genome Editing/Genome Engineering Market Between 2026 And 2030?

    The genome editing/genome engineering market size has experienced rapid expansion in recent years. It is anticipated to increase from $10.17 billion in 2025 to $12.15 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 19.5%. The historical growth of this market can be attributed to several factors including the discovery of genome editing techniques, their early applications in research, the increasing availability of molecular biology tools, a rise in academic research funding, and the demand for disease modeling.

    The genome editing/genome engineering market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $24.53 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 19.2%. This anticipated growth during the forecast period stems from factors such as the clinical implementation of gene editing therapies, the broadening scope of agricultural genomics, advancements in editing precision, the establishment of ethical guidelines, and the increasing commercial availability of genome editing services. Key trends identified for this period encompass the wider embrace of CRISPR-based editing technologies, the extended application of genome editing in disease studies, a surge in the utilization of cell line engineering, a heightened need for precise gene alteration, and greater investment in research from academic and governmental bodies.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/report/genome-editing-or-genome-engineering-global-market-report

    What Significant Factors Are Influencing The Genome Editing/Genome Engineering Market Expansion?

    The genome editing and genome engineering market is anticipated to experience growth driven by an increase in research activities. Research activities involve systematic and structured efforts undertaken by individuals, teams, or organizations to collect, analyze, interpret, and produce new knowledge or insights in a particular academic domain. Genome editing and genome engineering have become essential enablers in the burgeoning field of research, fundamentally transforming scientific exploration. These groundbreaking tools empower scientists to precisely modify and deeply comprehend the intricate genetic blueprint of organisms, offering unparalleled exactitude and adaptability. For instance, in July 2023, according to National Institute of Neurological Disorders and Stroke, a US-based government research institute, reported that NIH awards more than $140 million to help accelerate genome editing approaches from the lab to the clinic. Consequently, the expansion of research activities is a key force propelling the genome editing and genome engineering market.

    How Are Segments Identified Within The Genome Editing/Genome Engineering Market Segment Framework?

    The genome editing/genome engineering market covered in this report is segmented –

    1) By Product And Service: Reagents And Consumables, Software And Systems, Services

    2) By Technology: CRISPR, TALEN, ZFN, Antisense, Other Technologies

    3) By Application: Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery And Development, Other Applications

    4) By End User: Biotechnology Companies, Pharmaceutical Companies, Academic And Government Research Institutes

    Subsegments:

    1) By Reagents And Consumables: CRISPR Or Cas9 Kits, TALENs Kits, Zinc Finger Nucleases (ZFNs), Donor DNA Templates, Nucleotide Reagents

    2) By Software And Systems: Genome Editing Design Software, Analysis And Visualization Tools, Workflow Management Systems

    3) By Services: Gene Synthesis And Cloning Services, Custom Genome Editing Services, Consulting Services For Genome Editing Projects

    What Trends Are Affecting The Direction Of The Genome Editing/Genome Engineering Market?

    Leading companies are forming collaborations and strategic partnerships to strengthen their position within the genome editing and genome engineering market. A strategic business partnership involves a structured affiliation between two or more commercial entities, typically established through one or more business agreements or contracts. For instance, in April 2024, Regeneron Pharmaceuticals, a US-based biopharmaceutical company focused on developing medicines in immunology, oncology, and genetic diseases, initiated a collaboration with Mammoth Biosciences, a US-based biotech firm founded by Jennifer Doudna specializing in CRISPR-based gene editing. Through this partnership, Regeneron aims to utilize Mammoth’s ultra-small CRISPR platforms alongside Regeneron’s delivery technologies to accelerate the development of in vivo gene editing therapies for tissues beyond the liver, thereby expanding Regeneron’s therapeutic pipeline and technological reach. Mammoth Biosciences is a U.S.-based company that provides CRISPR-based genome editing systems, including its proprietary small Cas enzymes, for therapeutic and diagnostic applications.

    Who Are The Companies Competing Within The Genome Editing/Genome Engineering Market?

    Major companies operating in the genome editing/genome engineering market are Thermo Fisher Scientific Inc., Merck Group, Genscript Biotech Corp, Sangamo Therapeutics Inc., Lonza Group AG, Editas Medicine Inc., CRISPR Therapeutics AG, Agilent Technologies Inc., Intellia Therapeutics, bluebird bio Inc., Transposagen Biopharmaceuticals Inc., Tecan Trading AG, Precision BioSciences, PerkinElmer Inc., Cellectis S.A, Applied StemCell Inc., Bio-Rad Laboratories Inc., Bio-Techne, Creative Biogene, Cyagen Biosciences, Dharmacon Inc., Eurofins Genomics LLC, Evotec SE, GeneCopoeia Inc., Genewiz, Horizon Discovery Group PLC, Inscripta Inc., Integrated DNA Technologies Inc., MaxCyte Inc., New England Biolabs, Novartis International AG.

    Get The Full Genome Editing/Genome Engineering Market Report:

    https://www.thebusinessresearchcompany.com/report/genome-editing-or-genome-engineering-global-market-report

    Which Region Is The Largest In The Genome Editing/Genome Engineering Market?

    North America was the largest region in the gene editing/genome engineering market in 2025. Asia-Pacific is expected to be the fastest-growing region in the genome editing/genome engineering market report during the forecast period. The regions covered in the genome editing/genome engineering market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Genome Editing/Genome Engineering Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/report/genome-editing-or-genome-engineering-global-market-report

    Browse Through More Reports Similar to the Global Genome Editing/Genome Engineering Market 2026, By The Business Research Company

    Gene Synthesis Market Report 2026

    https://www.thebusinessresearchcompany.com/report/gene-synthesis-global-market-report

    Gene Editing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report

    Crispr Gene Editing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/crispr-gene-editing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Genome Editing/Genome Engineering Market Forecast 2026–2035 Reflecting Expansion Opportunities Across Industries

    Genome Editing/Genome Engineering Market Forecast 2026–2035 Reflecting Expansion Opportunities Across Industries

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    How Much Is The Genome Editing/Genome Engineering Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

    The market size for genome editing/genome engineering has seen rapid expansion in recent years. It is anticipated to grow from $10.17 billion in 2025 to $12.15 billion in 2026, achieving a compound annual growth rate (CAGR) of 19.5%. Historically, this growth can be attributed to the discovery of genome editing techniques, early research applications, the availability of molecular biology tools, an increase in academic research funding, and the demand for disease modeling.

    The genome editing/genome engineering market is set to experience substantial expansion over the next few years. Its valuation is projected to reach $24.53 billion by 2030, advancing at a compound annual growth rate (CAGR) of 19.2%. This anticipated increase during the forecast period is primarily driven by the clinical application of gene editing therapies, the growing reach of agricultural genomics, enhanced accuracy in editing techniques, the development of ethical guidelines, and the commercialization of various genome editing services. Significant trends expected in the forecast period include the increasing uptake of CRISPR-based editing instruments, the broadening use of genome editing in disease research, a surge in cell line engineering applications, an escalating need for precise gene modification, and amplified research funding from academic and government bodies.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=8010&type=smp

    What Key Drivers Are Influencing The Growth Of The Genome Editing/Genome Engineering Market?

    The genome editing and genome engineering market is projected to grow, driven by an uptick in research activities. These activities encompass structured and methodical endeavors undertaken by researchers, groups, or organizations to collect, evaluate, understand, and produce novel information or understanding within a specific academic area. Crucially, genome editing and genome engineering have emerged as key drivers amidst the escalating volume of research, fundamentally altering the realm of scientific discovery. Such innovative instruments provide scientists with the capability to precisely alter and thoroughly grasp the complex genetic makeup of living beings, presenting unmatched accuracy and adaptability. As an illustration, the National Institute of Neurological Disorders and Stroke, a US-based government research institute, stated in July 2023 that the NIH allocated over $140 million to expedite the transition of genome editing methods from laboratory settings to clinical applications. Consequently, the expanding scope of research activities is propelling the genome editing and genome engineering market.

    What Major Segment Divisions Exist Within The Genome Editing/Genome Engineering Market?

    The genome editing/genome engineering market covered in this report is segmented –

    1) By Product And Service: Reagents And Consumables, Software And Systems, Services

    2) By Technology: CRISPR, TALEN, ZFN, Antisense, Other Technologies

    3) By Application: Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery And Development, Other Applications

    4) By End User: Biotechnology Companies, Pharmaceutical Companies, Academic And Government Research Institutes

    Subsegments:

    1) By Reagents And Consumables: CRISPR Or Cas9 Kits, TALENs Kits, Zinc Finger Nucleases (ZFNs), Donor DNA Templates, Nucleotide Reagents

    2) By Software And Systems: Genome Editing Design Software, Analysis And Visualization Tools, Workflow Management Systems

    3) By Services: Gene Synthesis And Cloning Services, Custom Genome Editing Services, Consulting Services For Genome Editing Projects

    How Are Trends Transforming The Genome Editing/Genome Engineering Market Landscape?

    Leading firms are forming alliances and entering into partnerships to enhance their position within the genome editing and genome engineering sector. Such strategic business partnerships involve a formalized association between two or more commercial entities, typically established through business agreements or contracts. For instance, in April 2024, Regeneron Pharmaceuticals, a US-based biopharmaceutical company specializing in immunology, oncology, and genetic illnesses, established a collaboration with Mammoth Biosciences, a US-based biotech firm co-founded by Jennifer Doudna, known for its expertise in CRISPR-based gene editing. Through this alliance, Regeneron intends to integrate Mammoth’s unique ultra-small CRISPR platforms with its own delivery technologies to expedite the creation of in vivo gene editing treatments for tissues beyond the liver, thereby broadening Regeneron’s therapeutic offerings and technological capabilities. Mammoth Biosciences, a company based in the United States, offers CRISPR-based genome editing systems, including its proprietary small Cas enzymes, for both therapeutic and diagnostic applications.

    Which Companies Are Leading Innovation In The Genome Editing/Genome Engineering Market?

    Major companies operating in the genome editing/genome engineering market are Thermo Fisher Scientific Inc., Merck Group, Genscript Biotech Corp, Sangamo Therapeutics Inc., Lonza Group AG, Editas Medicine Inc., CRISPR Therapeutics AG, Agilent Technologies Inc., Intellia Therapeutics, bluebird bio Inc., Transposagen Biopharmaceuticals Inc., Tecan Trading AG, Precision BioSciences, PerkinElmer Inc., Cellectis S.A, Applied StemCell Inc., Bio-Rad Laboratories Inc., Bio-Techne, Creative Biogene, Cyagen Biosciences, Dharmacon Inc., Eurofins Genomics LLC, Evotec SE, GeneCopoeia Inc., Genewiz, Horizon Discovery Group PLC, Inscripta Inc., Integrated DNA Technologies Inc., MaxCyte Inc., New England Biolabs, Novartis International AG.

    Read the full genome editing/genome engineering market report here:

    https://www.thebusinessresearchcompany.com/report/genome-editing-or-genome-engineering-global-market-report

    Which Region Is Expected To Register The Fastest Growth In The Genome Editing/Genome Engineering Market?

    North America was the largest region in the gene editing/genome engineering market in 2025. Asia-Pacific is expected to be the fastest-growing region in the genome editing/genome engineering market report during the forecast period. The regions covered in the genome editing/genome engineering market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Genome Editing/Genome Engineering Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=8010&type=smp

    Browse Through More Reports Similar to the Global Genome Editing/Genome Engineering Market 2026, By The Business Research Company

    Warts Therapeutics Global Market Report

    https://www.thebusinessresearchcompany.com/report/warts-therapeutics-global-market-report

    Genital Herpes Global Market Report

    https://www.thebusinessresearchcompany.com/report/genital-herpes-global-market-report

    Vaginal Sling Global Market Report

    https://www.thebusinessresearchcompany.com/report/vaginal-sling-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Genome Editing/Genome Engineering Market Forecast: How Big Will It Be by 2030?

    Genome Editing/Genome Engineering Market Forecast: How Big Will It Be by 2030?

    Uncover key drivers, emerging technologies, and competitive movements shaping the genome editing/genome engineering market from 2026–2035 with trusted insights from The Business Research Company

    Starting from its 2026 valuation, what market size is the Genome Editing/Genome Engineering Market expected to reach by 2030?

    The genome editing/genome engineering market has witnessed rapid growth in recent years. It is projected to expand from $10.17 billion in 2025 to $12.15 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 19.5%. This historic period of growth can be attributed to key factors including the discovery of genome editing techniques, their initial applications in research, the availability of molecular biology tools, increased academic research funding, and the rising demand for disease modeling.

    The genome editing/genome engineering market size is projected to experience substantial expansion in the coming years. This market is anticipated to reach a valuation of $24.53 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 19.2%. Factors contributing to this growth during the forecast period include the clinical application of gene editing treatments, the broadening scope of agricultural genomics, advancements in editing precision, the establishment of ethical guidelines, and the increased availability of commercial genome editing services. Key trends anticipated in the same period involve a greater embrace of CRISPR-based editing technologies, the wider utilization of genome editing in disease investigations, an uptick in cell line engineering uses, a rising need for precise gene alterations, and enhanced financial support from academic and governmental bodies for research.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=8010&type=smp

    What Drivers Are Driving Adoption Within The Genome Editing/Genome Engineering Market?

    The anticipated growth of the genome editing and genome engineering market is expected to be propelled by an escalation in research activities. These activities encompass systematic and organized endeavors undertaken by individuals, teams, or institutions to collect, analyze, interpret, and generate new knowledge or insights within a specific field of study. Genome editing and genome engineering have evolved into critical accelerators in the increasing trend of research, thereby reshaping the panorama of scientific exploration. These innovative tools empower researchers to meticulously modify and grasp the complex genetic structure of organisms, offering unparalleled precision and adaptability. For instance, in July 2023, the National Institute of Neurological Disorders and Stroke, a US-based government research institute, reported that NIH granted over $140 million to facilitate the acceleration of genome editing approaches from laboratory research to clinical implementation. Therefore, the rise in research activities is a primary driver for the genome editing and genome engineering market.

    What Segments Are Included Within The Genome Editing/Genome Engineering Market?

    The genome editing/genome engineering market covered in this report is segmented –

    1) By Product And Service: Reagents And Consumables, Software And Systems, Services

    2) By Technology: CRISPR, TALEN, ZFN, Antisense, Other Technologies

    3) By Application: Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery And Development, Other Applications

    4) By End User: Biotechnology Companies, Pharmaceutical Companies, Academic And Government Research Institutes

    Subsegments:

    1) By Reagents And Consumables: CRISPR Or Cas9 Kits, TALENs Kits, Zinc Finger Nucleases (ZFNs), Donor DNA Templates, Nucleotide Reagents

    2) By Software And Systems: Genome Editing Design Software, Analysis And Visualization Tools, Workflow Management Systems

    3) By Services: Gene Synthesis And Cloning Services, Custom Genome Editing Services, Consulting Services For Genome Editing Projects

    Which Market Trends Are Opening Growth Opportunities In The Genome Editing/Genome Engineering Market?

    Leading firms form alliances and enter into collaborations to enhance their standing within the genome editing and genome engineering market. A strategic business partnership denotes a formalized relationship between multiple commercial entities, usually formalized through specific business agreements or contractual arrangements. For example, in April 2024, Regeneron Pharmaceuticals, a biopharmaceutical company based in the US specializing in medicines for immunology, oncology, and genetic diseases, initiated a collaboration with Mammoth Biosciences, a US-based biotech company established by Jennifer Doudna, known for its expertise in CRISPR-based gene editing. Through this alliance, Regeneron intends to utilize Mammoth’s ultra-small CRISPR platforms in conjunction with Regeneron’s delivery innovations to expedite the creation of in vivo gene editing treatments for tissues outside the liver, consequently broadening Regeneron’s therapeutic offerings and technological capabilities. Mammoth Biosciences, a US-based entity, supplies CRISPR-based genome editing systems, including its proprietary small Cas enzymes, for both therapeutic and diagnostic uses.

    Who Are The Prominent Global Companies Shaping The Genome Editing/Genome Engineering Market Landscape?

    Major companies operating in the genome editing/genome engineering market are Thermo Fisher Scientific Inc., Merck Group, Genscript Biotech Corp, Sangamo Therapeutics Inc., Lonza Group AG, Editas Medicine Inc., CRISPR Therapeutics AG, Agilent Technologies Inc., Intellia Therapeutics, bluebird bio Inc., Transposagen Biopharmaceuticals Inc., Tecan Trading AG, Precision BioSciences, PerkinElmer Inc., Cellectis S.A, Applied StemCell Inc., Bio-Rad Laboratories Inc., Bio-Techne, Creative Biogene, Cyagen Biosciences, Dharmacon Inc., Eurofins Genomics LLC, Evotec SE, GeneCopoeia Inc., Genewiz, Horizon Discovery Group PLC, Inscripta Inc., Integrated DNA Technologies Inc., MaxCyte Inc., New England Biolabs, Novartis International AG.

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/genome-editing-or-genome-engineering-global-market-report

    Which Region Is Projected To Lead The Genome Editing/Genome Engineering Market During The Forecast Period?

    North America was the largest region in the gene editing/genome engineering market in 2025. Asia-Pacific is expected to be the fastest-growing region in the genome editing/genome engineering market report during the forecast period. The regions covered in the genome editing/genome engineering market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Genome Editing/Genome Engineering Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=8010&type=smp

    Browse Through More Reports Similar to the Global Genome Editing/Genome Engineering Market 2026, By The Business Research Company

    Gene Synthesis Market Report 2026

    https://www.thebusinessresearchcompany.com/report/gene-synthesis-global-market-report

    Gene Editing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report

    Crispr Gene Editing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/crispr-gene-editing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • What Key Growth Drivers Are Shaping The Genome Editing/Genome Engineering Market Forecast Toward $20.64 Billion?

    What Key Growth Drivers Are Shaping The Genome Editing/Genome Engineering Market Forecast Toward $20.64 Billion?

    Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

    How Much Will The Genome Editing/Genome Engineering Market Be Worth By 2029?

    The market size for genome editing/genome engineering has seen accelerated growth over the last few years. The market, valued at $8.62 billion in 2024, is expected to reach $10.17 billion in 2025 with a compound annual growth rate (CAGR) of 17.9%. The robust growth witnessed during this historical period can be credited to factors such as intensified research in the field of genetics and genomics, increasing instances of genetic diseases, advancements in gene therapy techniques, significant investments channelled towards biotechnology and life sciences, potential applications in agriculture, and usage in model organisms.

    The market size of genome editing/genome engineering is predicted to undergo swift expansion in the coming years. The market is anticipated to escalate to $20.64 billion in 2029, with a compound annual growth rate (CAGR) of 19.4%. Factors contributing to this growth during the forecast period include the advent of prime editing, the concentration on ethical and regulatory infrastructures, its increasing use in drug exploration, its therapeutic potential for genetic ailments, its customization for gene functionality studies, and the rising interest in epigenome editing. Key trends within the projected period encompass advancements in Crispr technology, increasing applications in therapeutic practices, the introduction of new genome editing tools, higher levels of investments and partnerships, improved delivery systems, and the incorporation of artificial intelligence (AI) in genome editing design.

    Get A Free Sample Of The Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=8010&type=smp

    What Market Forces Are Contributing To The Growth Of The Genome Editing/Genome Engineering Market?

    The escalating incidences of cancer and other genetic anomalies are anticipated to spur the expansion of the genome editing/genome engineering market. Cancer occurs when some of the body’s cells proliferate uncontrollably and invade other parts of the body. Genome editing has the potential to rapidly modify immune cells and oncolytic viruses for use in cancer treatments. For instance, the World Health Organization (WHO), a United Nations health agency based in Switzerland, disclosed in an article from February 2022 that almost 10 million deaths, equivalent to nearly one in six, were due to cancer, thereby ranking it as the world’s leading cause of mortality. Further, according to a report released by the Centers for Disease Control and Prevention (CDC) in June 2022, a US-based national public health agency reported that in 2019, the US saw 1,752,735 new instances of invasive cancer overall, comprising 863,830 women and 888,905 men. The overall cancer incidence rate was noted to be 439 per 100,000 people. Accordingly, the increasing instances of cancer and other genetic anomalies are facilitating the expansion of the genome editing and genome engineering market.

    Which Segments Define The Structure Of The Genome Editing/Genome Engineering Market?

    The genome editing/genome engineeringmarket covered in this report is segmented –

    1) By Product And Service: Reagents And Consumables; Software And systems; Services

    2) By Technology: CRISPR; TALEN; ZFN; Antisense; Other Technologies

    3) By Application: Cell Line Engineering; Genetic Engineering; Diagnostic Applications; Drug Discovery And Development; Other Applications

    4) By End User: Biotechnology Companies; Pharmaceutical Companies; Academic And Government Research Institutes

    Subsegments:

    1) By Reagents And Consumables: CRISPR Or Cas9 Kits; TALENs Kits; Zinc Finger Nucleases (ZFNs); Donor DNA Templates; Nucleotide Reagents

    2) By Software And Systems: Genome Editing Design Software; Analysis And Visualization Tools; Workflow Management Systems

    3) By Services: Gene Synthesis And Cloning Services; Custom Genome Editing Services; Consulting Services For Genome Editing Projects

    Which Disruptive Trends Are Driving Change Across The Genome Editing/Genome Engineering Market?

    The trend of major technological strides in gene editing is gaining steam in the genome editing/genome engineering market. Major market players are focusing on devising novel technology solutions to enhance their standing. For instance, in May 2022, a joint endeavor between Kyoto University and the Institute of Evolutionary Biology (CSIC-Universitat Pompeu Fabra), a Spain-based research institution that specializes in evolutionary biology, introduced a fast and efficient technique for gene editing in insects. This method, named Direct parental CRISPR (DIPA-CRISPR), involves the injection of substances into growing eggs within adult females, rather than directly into embryos. This groundbreaking method allows researchers to circumvent the process of microinjecting CRISPR material into insect embryos.

    Which Firms Are Making The Biggest Impact In The Genome Editing/Genome Engineering Market?

    Major companies operating in the genome editing/genome engineering market are Thermo Fisher Scientific Inc., Merck Group, Genscript Biotech Corp, Sangamo Therapeutics Inc., Lonza Group AG, Editas Medicine Inc., CRISPR Therapeutics AG, Agilent Technologies Inc., Intellia Therapeutics, bluebird bio Inc., Transposagen Biopharmaceuticals Inc., Tecan Trading AG, Precision BioSciences, PerkinElmer Inc., Cellectis S.A, Applied StemCell Inc., Bio-Rad Laboratories Inc., Bio-Techne, Creative Biogene, Cyagen Biosciences, Dharmacon Inc., Eurofins Genomics LLC, Evotec SE, GeneCopoeia Inc., Genewiz, Horizon Discovery Group PLC, Inscripta Inc., Integrated DNA Technologies Inc., MaxCyte Inc., New England Biolabs, Novartis International AG.

    Access The Complete Report Here:

    https://www.thebusinessresearchcompany.com/report/genome-editing-or-genome-engineering-global-market-report

    Which Region Is Forecasted To Lead The Genome Editing/Genome Engineering Market In The Coming Years?

    North America was the largest region in the gene editing/genome engineering market in 2024. Asia-Pacific is expected to be the fastest-growing region in the genome editing/genome engineering market report during the forecast period. The regions covered in the genome editing/genome engineering market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Customize Your Report Here:

    https://www.thebusinessresearchcompany.com/customise?id=8010&type=smp

    Browse Through More Reports Similar to the Global Genome Editing/Genome Engineering Market 2025, By The Business Research Company

    Gene Editing Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report

    Genes Therapy Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

    Cell And Genes Therapy Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Genome Editing/Genome Engineering Market Growth Opportunities: Insights from 2025–2029

    Genome Editing/Genome Engineering Market Growth Opportunities: Insights from 2025–2029

    Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

    By How Much Is The Genome Editing/Genome Engineering Market Expected To Expand Between 2025 And 2029?

    The genome editing/genome engineering market has experienced significant expansion in recent years. It is forecast to increase from $8.62 billion in 2024 to $10.17 billion in 2025, reflecting a compound annual growth rate (CAGR) of 17.9%. The past growth in this sector is attributed to factors such as increasing research in genetics and genomics, a rise in genetic diseases, advancements in gene therapy, investments in biotechnology and life sciences, the potential for agricultural applications, and its use in model organisms.

    The genome editing/genome engineering market is anticipated to grow significantly in the coming years. By 2029, it is forecast to reach a valuation of $20.64 billion, exhibiting a compound annual growth rate (CAGR) of 19.4%. This expansion during the forecast period is largely due to factors such as the advent of prime editing, increased attention on ethical and regulatory guidelines, wider use in drug discovery, its therapeutic capabilities for genetic conditions, tailored applications for gene function research, and rising engagement with epigenome editing. Key developments anticipated in this period encompass progress in Crispr technology, expanding therapeutic applications, the introduction of novel genome editing instruments, increased investments and collaborative ventures, improved delivery mechanisms, and the incorporation of artificial intelligence (AI) into genome editing design.

    Unlock Your Free Sample Report for Exclusive Market Data:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=8010&type=smp

    Which Factors And Drivers Are Influencing The Genome Editing/Genome Engineering Market In 2025?

    The increasing prevalence of cancer and other genetic disorders is anticipated to drive the future growth of the genome editing/genome engineering market. Cancer involves certain body cells growing uncontrollably and spreading to other regions, a condition for which genome editing offers a rapid method to engineer immune cells and oncolytic viruses for therapeutic applications. For example, an article published by the World Health Organization (WHO), a Switzerland-based United Nations health agency, in February 2022, revealed that cancer accounted for nearly 10 million deaths, or approximately one in six deaths, globally, making it the leading cause of death worldwide. Additionally, a report from the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, in June 2022, indicated that 1,752,735 new cases of invasive cancer were reported in the US in 2019, including 863,830 women and 888,905 men. The incidence rate for all cancers was 439 per 100,000 people in the general population. Therefore, the heightened occurrence of cancer and various genetic disorders is a significant factor propelling the expansion of the genome editing and genome engineering market.

    What Are The Major Segment Categories Driving The Genome Editing/Genome Engineering Market Growth?

    The genome editing/genome engineeringmarket covered in this report is segmented –

    1) By Product And Service: Reagents And Consumables; Software And systems; Services

    2) By Technology: CRISPR; TALEN; ZFN; Antisense; Other Technologies

    3) By Application: Cell Line Engineering; Genetic Engineering; Diagnostic Applications; Drug Discovery And Development; Other Applications

    4) By End User: Biotechnology Companies; Pharmaceutical Companies; Academic And Government Research Institutes

    Subsegments:

    1) By Reagents And Consumables: CRISPR Or Cas9 Kits; TALENs Kits; Zinc Finger Nucleases (ZFNs); Donor DNA Templates; Nucleotide Reagents

    2) By Software And Systems: Genome Editing Design Software; Analysis And Visualization Tools; Workflow Management Systems

    3) By Services: Gene Synthesis And Cloning Services; Custom Genome Editing Services; Consulting Services For Genome Editing Projects

    Which Competitive Trends Are Defining The Genome Editing/Genome Engineering Market Structure?

    Technological progress in gene editing is a key trend gaining traction in the genome editing/genome engineering market. Major companies operating in the genome editing/genome engineering market are concentrating on developing innovative technology solutions to improve their standing. For instance, in May 2022, researchers at Kyoto University and the Institute of Evolutionary Biology (CSIC-Universitat Pompeu Fabra), a Spain-based research university focused on evolutionary biology, unveiled a swift and effective method for editing genes in insects. Direct parental CRISPR (DIPA-CRISPR), a simple and effective method, involves injecting materials into developing eggs in female adults rather than into embryos. This novel technique enables researchers to avoid the microinjection of CRISPR material into insect embryos.

    Which Leading Players Are Enhancing Their Genome Editing/Genome Engineering Market Presence Worldwide?

    Major companies operating in the genome editing/genome engineering market are Thermo Fisher Scientific Inc., Merck Group, Genscript Biotech Corp, Sangamo Therapeutics Inc., Lonza Group AG, Editas Medicine Inc., CRISPR Therapeutics AG, Agilent Technologies Inc., Intellia Therapeutics, bluebird bio Inc., Transposagen Biopharmaceuticals Inc., Tecan Trading AG, Precision BioSciences, PerkinElmer Inc., Cellectis S.A, Applied StemCell Inc., Bio-Rad Laboratories Inc., Bio-Techne, Creative Biogene, Cyagen Biosciences, Dharmacon Inc., Eurofins Genomics LLC, Evotec SE, GeneCopoeia Inc., Genewiz, Horizon Discovery Group PLC, Inscripta Inc., Integrated DNA Technologies Inc., MaxCyte Inc., New England Biolabs, Novartis International AG.

    Download The Full Report For Exclusive Market Findings:

    https://www.thebusinessresearchcompany.com/report/genome-editing-or-genome-engineering-global-market-report

    How Do Regional Market Performances Compare Within The Genome Editing/Genome Engineering Industry?

    North America was the largest region in the gene editing/genome engineering market in 2024. Asia-Pacific is expected to be the fastest-growing region in the genome editing/genome engineering market report during the forecast period. The regions covered in the genome editing/genome engineering market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Version Of The Genome Editing/Genome Engineering Market Report:

    https://www.thebusinessresearchcompany.com/customise?id=8010&type=smp

    Browse Through More Reports Similar to the Global Genome Editing/Genome Engineering Market 2025, By The Business Research Company

    Gene Editing Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report

    Genes Therapy Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

    Cell And Genes Therapy Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Genome Editing/Genome Engineering Market Forecast Reaching $20.64 Billion by 2029 at 19.4% CAGR

    Genome Editing/Genome Engineering Market Forecast Reaching $20.64 Billion by 2029 at 19.4% CAGR

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    What Is the Estimated Market Size of the Genome Editing/Genome Engineering Market In 2029?

    In recent times, the market size for genome editing/genome engineering has witnessed impressive growth. Expected to escalate from $8.62 billion in 2024 to $10.17 billion in 2025, the market is predicted to grow at a compound annual growth rate (CAGR) of 17.9%. The historic growth rate is influenced by factors such as increasing genetic and genomic research, a surge in genetic diseases, advancements in gene therapy, investments funneled into biotechnology and life sciences, as well as its potential use in agricultural applications and in model organisms.

    The market for genome editing/genome engineering is predicted to experience swift expansion in the coming years, with projections estimating it to reach $20.64 billion in 2029, showcasing a compound annual growth rate (CAGR) of 19.4%. This projected growth during the forecasted period can be linked to factors such as the advent of prime editing, emphasis on ethical and regulatory structures, heightened utilization in drug discovery, the therapeutic potential for genetic conditions, bespoke options for gene function studies, and increased intrigue in the editing of the epigenome. The prospective trends for this period encapsulate advancements in Crispr technology, expanding applications in therapeutic strategies, the surfacing of new genome editing tools, collaborations and investments, improvements in delivery mechanisms, and the incorporation of artificial intelligence (AI) within genome editing design.

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=8010&type=smp

    Which Major Market Drivers Are Expected to Boost the Growth Potential of the Genome Editing/Genome Engineering Market?

    The growing incidence of cancer and other genetic disorders is expected to drive the expansion of the genome editing/genome engineering market. Cancer is a disease where certain body cells multiply uncontrollably and migrate to other parts of the body. Genome editing has the capability to swiftly modify immune cells and oncolytic viruses for cancer treatment. As an example, in February 2022, as per an article by the World Health Organization (WHO), a health agency based in Switzerland, cancer was responsible for almost 10 million deaths, or approximately one in six deaths, cementing its position as the leading global cause of death. Moreover, in June 2022, a report by the Centers for Disease Control and Prevention (CDC), a national public health agency in the US, revealed 1,752,735 new cases of invasive cancer in total, with 863,830 women and 888,905 men affected in the US in 2019. The rate of cancer for all types was 439 per 100,000 people in the general population. Consequently, the increasing prevalence of cancer and other genetic disorders is stimulating the genome editing and genome engineering market growth.

    Which Key Market Segments Comprise the Genome Editing/Genome Engineering Market and Drive Its Revenue Growth?

    The genome editing/genome engineeringmarket covered in this report is segmented –

    1) By Product And Service: Reagents And Consumables; Software And systems; Services

    2) By Technology: CRISPR; TALEN; ZFN; Antisense; Other Technologies

    3) By Application: Cell Line Engineering; Genetic Engineering; Diagnostic Applications; Drug Discovery And Development; Other Applications

    4) By End User: Biotechnology Companies; Pharmaceutical Companies; Academic And Government Research Institutes

    Subsegments:

    1) By Reagents And Consumables: CRISPR Or Cas9 Kits; TALENs Kits; Zinc Finger Nucleases (ZFNs); Donor DNA Templates; Nucleotide Reagents

    2) By Software And Systems: Genome Editing Design Software; Analysis And Visualization Tools; Workflow Management Systems

    3) By Services: Gene Synthesis And Cloning Services; Custom Genome Editing Services; Consulting Services For Genome Editing Projects

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=8010&type=smp

    Which Areas Are Leading Regions in the Genome Editing/Genome Engineering Market Expansion Across the Globe?

    North America was the largest region in the gene editing/genome engineering market in 2024. Asia-Pacific is expected to be the fastest-growing region in the genome editing/genome engineering market report during the forecast period. The regions covered in the genome editing/genome engineering market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    What Are the Key Market Trends in theGenome Editing/Genome Engineering Market Over the Coming Years?

    The genome editing/genome engineering market is experiencing a surge in popularity due to key developments in gene editing technology. To enhance their market standing, dominant companies are focusing on the development of innovative technological solutions. For example, in May 2022, a new and efficient gene editing method for insects was revealed by researchers from Kyoto University and the Institute of Evolutionary Biology (CSIC-Universitat Pompeu Fabra), a research university in Spain specializing in evolutionary biology. The method, known as Direct parental CRISPR (DIPA-CRISPR), involves injection into the eggs in adult females instead of embryos, bypassing the need for microinjecting CRISPR material into insect embryos. This innovative procedure is both simple and effective.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/genome-editing-or-genome-engineering-global-market-report

    How Is the Genome Editing/Genome Engineering Market Conceptually Defined?

    Genome editing is a technique that enables scientists to alter the DNA of numerous organisms, including plants, bacteria, and animals. With the help of genome editing technologies, researchers would alter DNA, changing physical characteristics like eye color and the risk of contracting diseases. Genome editing is used in animal models and cells in research labs to understand diseases.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8010

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Europe +44 7882 955267

    Asia & Others +44 7882 955267 & +91 8897263534

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Growth Opportunities and Trends in the Genome Editing/Genome Engineering Market: Key Insights for 2025-2034

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    How Will the CAGR of the Genome Editing/Genome Engineering Market Influence Its Overall Growth by 2034?

    The market size for genome editing/genome engineering has experienced rapid expansion in the last few years. An upswing from $8.62 billion in 2024 to $10.2 billion in 2025 is expected, reflecting a compound annual growth rate (CAGR) of 18.2%. This significant growth during the historical period is largely due to progressive research in genetics and genomics, the increase in genetic diseases, advancements in gene therapy, investment growth in biotechnology and life sciences, the potential in agricultural applications, and the application in model organisms.

    In the coming years, the market for genome editing/engineering is projected to experience rapid expansion. The market is forecasted to increase to $20.81 billion by 2029, with a compound annual growth rate (CAGR) of 19.5%. Factors contributing to this estimated growth during the forecast period include the rise of prime editing, attention on moral and regulatory structures, increased use in drug discovery, the therapeutic potential for genetic disorders, customization for gene function investigations, and a heightened interest in epigenome editing. Key trends predicted for this period consist of advancements in Crispr technology, broadening uses in therapeutics, the introduction of new genome editing tools, investments and collaborations, improved delivery systems, and the incorporation of artificial intelligence (AI) in genome editing design.

    What Factors Are Propelling the Growth of the genome editing/genome engineering Market from 2025 to 2034?

    The increase in cases of cancer and other genetic diseases is poised to drive the expansion of the genome editing/engineering market. Cancer refers to diseases in which some of the body’s cells multiply uncontrollably and spread to other parts of the body. Genome editing has the ability to rapidly modify immune cells and oncolytic viruses for use in cancer treatments. For example, in February 2022, the World Health Organization (WHO), a Swiss United Nations health agency, published an article stating that approximately 10 million deaths, or nearly one in six worldwide, were attributed to cancer, marking it as the primary cause of death globally. Moreover, in June 2022, the Centers for Disease Control and Prevention (CDC), a United States national public health agency, published a report detailing 1,752,735 new incidences of invasive cancer, including 863,830 women and 888,905 men, reported in the US in 2019. The rate of all cancer incidences stood at 439 per 100,000 people across the general population. As such, the growing prevalence of cancer and genetic diseases is fueling the expansion of the genome editing and genome engineering market.

    Explore Comprehensive Insights Into The Global Genome Editing/Genome Engineering Market With A Free Sample Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=8010&type=smp

    Who Are the Leading Companies Pioneering Change in the Genome Editing/Genome Engineering Market?

    Major companies operating in the genome editing/genome engineering market are:

    • Thermo Fisher Scientific Inc._x000D_

    • Merck Group_x000D_

    • Genscript Biotech Corp_x000D_

    • Sangamo Therapeutics Inc._x000D_

    • Lonza Group AG_x000D_

    What Are the Most Significant Trends Transforming the Genome Editing/Genome Engineering Market Today?

    Gene editing tech advancements are a notable trend picking up pace in the genome editing/genome engineering space. Many leading companies in this market are putting emphasis on carving out innovative tech solutions to enhance their standing. Take for example, in May 2022, Kyoto University along with Institute of Evolutionary Biology (CSIC-Universitat Pompeu Fabra), a research university in Spain specialising in evolutionary biology, revealed an efficient and swift gene editing procedure for insects. This method, termed as Direct parental CRISPR (DIPA-CRISPR), involves the injection of materials into growing eggs in female adults as opposed to embryos. This groundbreaking method allows researchers to bypass microinjecting CRISPR material into insect embryos.

    Secure Your Global Genome Editing/Genome Engineering Market Report Now for Fast and Efficient Delivery!

    https://www.thebusinessresearchcompany.com/report/genome-editing-or-genome-engineering-global-market-report

    Which Market Segments Are Driving Strategic Growth and Trends in the Genome Editing/Genome Engineering Market?

    The genome editing/genome engineering market covered in this report is segmented –

    1) By Product And Service: Reagents And Consumables, Software And systems, Services

    2) By Technology: CRISPR, TALEN, ZFN, Antisense, Other Technologies

    3) By Application: Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery And Development, Other Applications

    4) By End User: Biotechnology Companies, Pharmaceutical Companies, Academic And Government Research Institutes

    Subsegments:

    1) By Reagents And Consumables: CRISPR Or Cas9 Kits, TALENs Kits, Zinc Finger Nucleases (ZFNs), Donor DNA Templates, Nucleotide Reagents

    2) By Software And Systems: Genome Editing Design Software, Analysis And Visualization Tools, Workflow Management Systems

    3) By Services: Gene Synthesis And Cloning Services, Custom Genome Editing Services, Consulting Services For Genome Editing Projects

    Which Regions Are Leading the Charge in Genome Editing/Genome Engineering Market Development?

    North America was the largest region in the gene editing/genome engineering market in 2024. Asia-Pacific is expected to be the fastest-growing region in the genome editing/genome engineering market report during the forecast period. The regions covered in the genome editing/genome engineering market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    How Is the Definition of the Genome Editing/Genome Engineering Market Impacting Future Growth?

    Genome editing is a technique that enables scientists to alter the DNA of numerous organisms, including plants, bacteria, and animals. With the help of genome editing technologies, researchers would alter DNA, changing physical characteristics like eye color and the risk of contracting diseases. Genome editing is used in animal models and cells in research labs to understand diseases.

    Browse Through More Similar Reports By The Business Research Company:

    Gene Editing Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report

    Cell and Gene Therapy Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report

    CRISPR Technology Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/crispr-technology-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on: